rifampin and stearic-acid

rifampin has been researched along with stearic-acid* in 2 studies

Other Studies

2 other study(ies) available for rifampin and stearic-acid

ArticleYear
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis.
    International journal of pharmaceutics, 2014, Feb-28, Volume: 462, Issue:1-2

    The goal of the work was to evaluate an anti-tubercular strategy based on breathable Solid Lipid Microparticles (SLM) to target alveolar macrophages and to increase the effectiveness of the conventional tuberculosis (TB) therapy. Rifampicin loaded SLM composed of stearic acid and sodium taurocholate were characterized for aerodynamic diameter, surface charge, physical state of the components, drug loading and release as well as drug biological activity on Bacillus subtilis strain. Moreover, SLM cytotoxicity and cell internalization ability were evaluated on murine macrophages J774 cell lines by MTT test, cytofluorimetry and confocal laser microscopy. SLM exhibited aerodynamic diameter proper to be transported up to the alveolar epithelium, negative charged surface able to promote uptake by the macrophages and preserved drug antimicrobial activity. The negligible in vitro release of rifampicin indicated the capacity of the microparticle matrix to entrap the drug preventing its spreading over the lung fluid. In vitro studies on J774 cell lines demonstrated SLM non-cytotoxicity and ability to be taken up by cell cytoplasm. The microparticulate carrier, showing features suitable for the inhaled therapy and for inducing endocytosis by alveolar macrophages, could be considered promising in a perspective of an efficacious TB inhaled therapy by means of a Dry Powder Inhaler device.

    Topics: Administration, Inhalation; Animals; Antitubercular Agents; Bacillus subtilis; Cell Line; Drug Carriers; Drug Delivery Systems; Dry Powder Inhalers; Flow Cytometry; Lipids; Macrophages, Alveolar; Mice; Microscopy, Confocal; Microspheres; Particle Size; Rifampin; Stearic Acids; Taurocholic Acid; Tuberculosis

2014
Dry powder cationic lipopolymeric nanomicelle inhalation for targeted delivery of antitubercular drug to alveolar macrophage.
    International journal of nanomedicine, 2013, Volume: 8

    Excipients having self-assembling properties are less explored in the field of dry powder inhalation (DPI) technology. An amphiphilic lipopolymer system was developed using stearic acid (SA) and branched polyethyleneimine (BPEI) (1800 Dalton), at different proportions by covalent conjugation. A molecular dynamic (MD) simulation tool was employed for predicting the carrier behavior in a polar in vivo condition. The structural characterization was carried out using nuclear magnetic resonance spectroscopy (NMR) and Fourier transform infrared (FTIR) spectroscopy. The physical nature of the lipopolymer was analyzed by differential scanning calorimetry. Determination of zeta potential and diameter of the micelles showed existence of cationic particles in the nano size range when a lower number of primary amino groups of BPEI was grafted with SA. The rifampicin (RIF)-loaded lipopolymer was also formulated further into spray-dried microparticles. Powder X-ray diffraction (PXRD) studies revealed that the RIF API (active pharmaceutical ingredient) exists as molecular dispersion in spray-dried microparticles. Topological analysis of the spray-dried nanomicelle was carried out using scanning electron microscopy (SEM). A large population of the drug-carrying particles were found to be under the inhalable size range (fine particle fraction 67.88% ± 3%). In vitro drug release kinetics from spray-dried nanomicelles were carried out at lung fluid pH.

    Topics: Antitubercular Agents; Cations; Cell Line, Tumor; Cell Survival; Drug Carriers; Humans; Macrophages; Microscopy, Confocal; Molecular Dynamics Simulation; Mycobacterium smegmatis; Nanoparticles; Polyethyleneimine; Powders; Rifampin; Stearic Acids

2013